Comparing the MicroRNA Spectrum between Serum and Plasma

Abstract MicroRNAs (miRNAs) are small, non-coding RNAs that regulate various biological processes, primarily through interaction with messenger RNAs. The levels of specific, circulating miRNAs in blood have been shown to associate with various pathological conditions including cancers. These miRNAs have great potential as biomarkers for various pathophysiological conditions. In this study we focused on different sample types’ effects on the spectrum of circulating miRNA in blood. Using serum and corresponding plasma samples from the same individuals, we observed higher miRNA concentrations in serum samples compared to the corresponding plasma samples. The difference between serum and plasma miRNA concentration showed some associations with miRNA from platelets, which may indicate that the coagulation process may affect the spectrum of extracellular miRNA in blood. Several miRNAs also showed platform dependent variations in measurements. Our results suggest that there are a number of factors that might affect the measurement of circulating miRNA concentration. Caution must be taken when comparing miRNA data generated from different sample types or measurement platforms.

[1]  Yue Li,et al.  Circulating microRNA: a novel potential biomarker for early diagnosis of acute myocardial infarction in humans. , 2010, European heart journal.

[2]  Eugene A. Kapp,et al.  Overview of the HUPO Plasma Proteome Project: Results from the pilot phase with 35 collaborating laboratories and multiple analytical groups, generating a core dataset of 3020 proteins and a publicly‐available database , 2005, Proteomics.

[3]  Takahiro Ochiya,et al.  Circulating microRNA in body fluid: a new potential biomarker for cancer diagnosis and prognosis , 2010, Cancer science.

[4]  Abdimajid Osman,et al.  Characterization of human platelet microRNA by quantitative PCR coupled with an annotation network for predicted target genes , 2011, Platelets.

[5]  Takahiro Ochiya,et al.  Secretory microRNAs as a versatile communication tool , 2010, Communicative & integrative biology.

[6]  Graham B. I. Scott,et al.  HUPO Plasma Proteome Project specimen collection and handling: Towards the standardization of parameters for plasma proteome samples , 2005, Proteomics.

[7]  Klaus Pantel,et al.  Cell-free nucleic acids as biomarkers in cancer patients , 2011, Nature Reviews Cancer.

[8]  Christoph Menzel,et al.  Prerequisites for peptidomic analysis of blood samples: I. Evaluation of blood specimen qualities and determination of technical performance characteristics. , 2005, Combinatorial chemistry & high throughput screening.

[9]  Sen-Yung Hsieh,et al.  Systematical evaluation of the effects of sample collection procedures on low‐molecular‐weight serum/plasma proteome profiling , 2006, Proteomics.

[10]  T. Avnit-Sagi,et al.  Epithelial microRNAs regulate gut mucosal immunity via epithelium–T cell crosstalk , 2011, Nature Immunology.

[11]  Keith W. Jones,et al.  Impact of Cellular miRNAs on Circulating miRNA Biomarker Signatures , 2011, PloS one.

[12]  Jessica A. Weber,et al.  The microRNA spectrum in 12 body fluids. , 2010, Clinical chemistry.

[13]  Inyoul Lee,et al.  Extracellular microRNA: a new source of biomarkers. , 2011, Mutation research.

[14]  Mohan Liu,et al.  Mechanisms of microRNA-mediated gene regulation , 2009, Science in China Series C: Life Sciences.

[15]  Gozoh Tsujimoto,et al.  Intra-Platform Repeatability and Inter-Platform Comparability of MicroRNA Microarray Technology , 2009, PloS one.

[16]  K. Yoshiura,et al.  Identification of pregnancy-associated microRNAs in maternal plasma. , 2010, Clinical chemistry.

[17]  Daniel B. Martin,et al.  Circulating microRNAs as stable blood-based markers for cancer detection , 2008, Proceedings of the National Academy of Sciences.

[18]  X. Chen,et al.  Serum microRNA profiles serve as novel biomarkers for HBV infection and diagnosis of HBV-positive hepatocarcinoma. , 2010, Cancer research.

[19]  K. Vickers,et al.  MicroRNAs are Transported in Plasma and Delivered to Recipient Cells by High-Density Lipoproteins , 2011, Nature Cell Biology.

[20]  G. Calin,et al.  MicroRNA history: discovery, recent applications, and next frontiers. , 2011, Mutation research.

[21]  R. Ach,et al.  Measuring microRNAs: Comparisons of microarray and quantitative PCR measurements, and of different total RNA prep methods , 2008, BMC biotechnology.

[22]  R. Nelson,et al.  Investigation of Human Protein Variants and Their Frequency in the General Population*S , 2007, Molecular & Cellular Proteomics.

[23]  H. Saya,et al.  Proteome profiling reveals gender differences in the composition of human serum , 2010, Proteomics.

[24]  Kunihiro Nishimura,et al.  Plasma microRNA 499 as a biomarker of acute myocardial infarction. , 2010, Clinical chemistry.

[25]  Shunsuke Noguchi,et al.  Microvesicle-mediated RNA molecule delivery system using monocytes/macrophages. , 2011, Molecular therapy : the journal of the American Society of Gene Therapy.

[26]  Jessica A. Weber,et al.  Export of microRNAs and microRNA-protective protein by mammalian cells , 2010, Nucleic acids research.

[27]  D Michiel Pegtel,et al.  Exosomes: Fit to deliver small RNA. , 2010, Communicative & integrative biology.

[28]  H. Tammen,et al.  Peptidomic analysis of human blood specimens: Comparison between plasma specimens and serum by differential peptide display , 2005, Proteomics.

[29]  L. Hood,et al.  Circulating microRNAs, potential biomarkers for drug-induced liver injury , 2009, Proceedings of the National Academy of Sciences.

[30]  D. Jacobowitz,et al.  Gender Dependence for a Subset of the Low-Abundance Signaling Proteome in Human Platelets , 2010, Human genomics and proteomics : HGP.

[31]  Jan A Staessen,et al.  Circulating MicroRNA-208b and MicroRNA-499 Reflect Myocardial Damage in Cardiovascular Disease , 2010, Circulation. Cardiovascular genetics.

[32]  Fátima Sánchez-Cabo,et al.  Unidirectional transfer of microRNA-loaded exosomes from T cells to antigen-presenting cells , 2011, Nature communications.

[33]  Frank D Sistare,et al.  Plasma MicroRNAs as sensitive and specific biomarkers of tissue injury. , 2009, Clinical chemistry.